Welcome to the 90th edition of Deep Tech Catalyst, the channel from The Scenarionist where science meets venture!
If you’ve been tracking the rise of alternative proteins, regulatory hurdles in food innovation, or the challenge of building B2B platforms in a consumer-driven industry, this episode is your roadmap.
Today, we’re joined by Amira Khatib, Vice President at Bluestein Ventures, to unpack what it really takes to build fundable companies at the frontier of food tech.
Together, we explore the strategic balancing act that defines this space—from early-stage regulatory navigation to capital-efficient prototyping, brand clarity, and corporate engagement.
In this edition, we explore:
Why market vs. technology is a false dichotomy in food tech
How to test products meaningfully—before FDA approval
When and how to fund the regulatory path at pre-seed
What makes a go-to-market strategy clear—and investable
How to partner with corporates without losing speed or leverage
Whether you’re a scientist spinning out lab innovation, an investor looking to de-risk food tech, or a founder navigating the early stages of commercialization—this conversation offers a grounded look at how to build real traction in a complex, capital-intensive sector.
Let’s dig in! 🥬
✨ For more, see Membership | Deep Tech Briefing | Insights | VC Guides
